
Adlai Nortye Ltd. American Depositary Shares
NASDAQ:ANL
1.45 (USD) • At close August 1, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Adlai Nortye Ltd. American Depositary Shares |
Symbool | ANL |
Munteenheid | USD |
Prijs | 1.45 |
Beurswaarde | 15,097,835 |
Dividendpercentage | 0% |
52-weken bereik | 1.1 - 3.89 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Yang Lu |
Website | https://www.adlainortye.com |
An error occurred while fetching data.
Over Adlai Nortye Ltd. American Depositary Shares
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)